These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16199478)

  • 21. Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.
    Wang B; Xu M; Li W; Li X; Zheng Q; Niu X
    PLoS One; 2017; 12(6):e0179648. PubMed ID: 28622359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
    Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
    Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.
    Cui Y; Wang Y; Liu G
    Pharm Biol; 2021 Dec; 59(1):1305-1313. PubMed ID: 34607503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction.
    Phrommintikul A; Tran L; Kompa A; Wang B; Adrahtas A; Cantwell D; Kelly DJ; Krum H
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1804-14. PubMed ID: 18245565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB activation is required for the development of cardiac hypertrophy in vivo.
    Li Y; Ha T; Gao X; Kelley J; Williams DL; Browder IW; Kao RL; Li C
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1712-20. PubMed ID: 15142841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress impairs myocyte autophagy, resulting in myocyte hypertrophy.
    Wang JP; Chi RF; Wang K; Ma T; Guo XF; Zhang XL; Li B; Qin FZ; Han XB; Fan BA
    Exp Physiol; 2018 Apr; 103(4):461-472. PubMed ID: 29327381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload.
    von Lueder TG; Gravning J; How OJ; Vinge LE; Ahmed MS; Krobert KA; Levy FO; Larsen TS; Smiseth OA; Aasum E; Attramadal H
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H66-74. PubMed ID: 22542621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy.
    Foo RS; Siow RC; Brown MJ; Bennett MR
    J Cell Physiol; 2006 Oct; 209(1):1-7. PubMed ID: 16826603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor.
    Wang X; McLennan SV; Allen TJ; Tsoutsman T; Semsarian C; Twigg SM
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1490-500. PubMed ID: 19625611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial reverse remodeling after pressure unloading is associated with maintained cardiac mechanoenergetics in a rat model of left ventricular hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Li S; Németh BT; Hegedűs P; Brlecic P; Mátyás C; Zorn M; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H592-603. PubMed ID: 27342874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy.
    Rossi MA; Peres LC
    Am Heart J; 1992 Sep; 124(3):700-9. PubMed ID: 1387507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TIR/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1.
    Fan M; Song J; He Y; Shen X; Li J; Que L; Zhu G; Zhu Q; Cai X; Ha T; Chen Q; Xu Y; Li C; Li Y
    Biochim Biophys Acta; 2016 Jun; 1862(6):1191-202. PubMed ID: 26964796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chemical chaperone 4-phenylbutyric acid attenuates pressure-overload cardiac hypertrophy by alleviating endoplasmic reticulum stress.
    Park CS; Cha H; Kwon EJ; Sreenivasaiah PK; Kim DH
    Biochem Biophys Res Commun; 2012 May; 421(3):578-84. PubMed ID: 22525677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
    Liu X; Li T; Sun S; Xu F; Wang Y
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H279-85. PubMed ID: 16100249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.
    Li B; Chi RF; Qin FZ; Guo XF
    Exp Physiol; 2016 Aug; 101(8):1050-63. PubMed ID: 27219474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.
    Takano APC; Munhoz CD; Moriscot AS; Gupta S; Barreto-Chaves MLM
    J Mol Med (Berl); 2017 Jun; 95(6):671-682. PubMed ID: 28161820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.